This opportunity funds research projects that apply advanced multimodal AI to integrate diverse human pancreas and clinical datasets for Type 1 Diabetes. The goal is to uncover biological interactions driving disease progression, identify biomarkers, and develop personalized medicine approaches. Projects will also create AI-enabled workflows and privacy-preserving synthetic datasets to accelerate T1D research.
Eligible applicants include a wide range of government entities, educational institutions, nonprofits, for-profit organizations, tribal governments, and foreign institutions. Specific eligibility details are extensive and diverse.
